Skip to content

Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts

Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05787249
Enrollment
1358
Registered
2023-03-28
Start date
2023-10-04
Completion date
2025-04-04
Last updated
2026-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast cancer, Breast density, Mammography

Brief summary

The goal of this study is to increase MRI utilization among women with extremely dense breasts. The main question it seeks to answer is whether nudging of the provider, patient, or both increases the uptake of MRI among this group, and whether this effect differs between Black and White women.

Detailed description

Women with dense breasts have 3-5-fold increased risk for breast cancer as women without dense breasts. Dense breast tissue can mask small tumors, leading to reduced mammography sensitivity. Recent randomized controlled trials demonstrate that supplemental breast MRI screening improves detection of small, invasive cancers that are not detected by mammography. In January 2022, a Pennsylvania law went into effect mandating insurance coverage of supplemental screening for women with extremely dense breasts. Currently only a small fraction of eligible women with extremely dense breasts are receiving supplemental breast MRI screening. Clinical pathways to identify patients who are eligible for insurance coverage of supplemental breast MRI screening and communicate this option to patients and providers are needed to ensure equitable access to supplemental screening. This study therefore proposes a stepped wedge cluster randomized clinical trial to determine whether electronic health record (EHR) and secure text message nudges increase utilization of supplemental breast MRI screening among eligible women with extremely dense breasts.

Interventions

BEHAVIORALPatient nudge

Nudge directed to the patient with the aim of increasing the uptake of MRI in patients with extremely dense breasts

BEHAVIORALProvider nudge

Nudge directed to the provider with the aim of increasing ordering of MRI in patients with extremely dense breasts

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Abramson Cancer Center at Penn Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

Patient participants: Inclusion Criteria: * Women aged 40-74 * Recent non-actionable mammogram of less than 6 months * Mammogram performed at Penn Center for Advanced Medicine, Penn Presbyterian Hospital, Pennsylvania Hospital, or Radnor * Valid mobile phone number

Exclusion criteria

* Prior history of breast cancer * No breast MRI within the past 2 years * No prior actionable mammogram within 6 months * No recent or concurrent ultrasound Provider participants: Inclusion Criteria: * Provider needs to have ordered the initial screening mammogram * Employed by Penn Health System and access to Penn Chart

Design outcomes

Primary

MeasureTime frameDescription
Ordering and/or scheduling of supplemental breast MRI6 monthsWhether a breast MRI is ordered and/or scheduled within 6 months of receiving a nudge.

Secondary

MeasureTime frameDescription
Ordering of breast MRI6 monthsWhether an MRI is ordered within 6 months of receiving a nudge. Analyzed separately from scheduling.
Scheduling of breast MRI6 monthsWhether an MRI is scheduled within 6 months of receiving a nudge. Analyzed separately from ordering.
Completion of breast MRI6 monthsWhether an MRI is completed within 6 months of receiving a nudge
False-positive rate6 monthsFalse-positive rate among those women who schedule and undergo MRI
Cancer detection rate6 monthsCancer detection rate among those women who schedule and undergo MRI

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026